Related references
Note: Only part of the references are listed.Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues
Lucas R. Massoth et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
SARS-CoV-2 has not been detected directly by electron microscopy in the endothelium of chilblain lesions
J. K. Brealey et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Discordantanti-SARS-CoV-2 spike protein andRNAstaining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein
Christine J. Ko et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
Timing of PCR and antibody testing in patients with COVID-19-associated dermatologic manifestations
Esther E. Freeman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Pediatric COVID toes and fingers
Merav Koschitzky et al.
CLINICS IN DERMATOLOGY (2021)
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak
L. Frumholtz et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
J. Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic
Thomas Hubiche et al.
JAMA DERMATOLOGY (2021)
Emerging Evidence of the Direct Association Between COVID-19 and Chilblains
Esther E. Freeman et al.
JAMA DERMATOLOGY (2021)
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases
Aristo Vojdani et al.
FRONTIERS IN IMMUNOLOGY (2021)
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins
Marc Emmenegger et al.
PLOS PATHOGENS (2021)
Diverse functional autoantibodies in patients with COVID-19
Eric Y. Wang et al.
NATURE (2021)
Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic
C. Cassius et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
The interferon landscape along the respiratory tract impacts the severity of COVID-19
Benedetta Sposito et al.
CELL (2021)
Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics
Nagarjuna R. Cheemarla et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic
Patrick E. McCleskey et al.
JAMA DERMATOLOGY (2021)
Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic
Valentina Discepolo et al.
JAMA NETWORK OPEN (2021)
Skin manifestations of COVID-19 in children: Part 1
D. Andina et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2021)
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases
C. Galvan Casas et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Novel outbreak of acral lesions in times of COVID-19: a description of 74 cases from a tertiary university hospital in Spain
A. Saenz Aguirre et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak
Diego Fernandez-Nieto et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries
Esther E. Freeman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serology
Kathy Kamath et al.
SCIENTIFIC REPORTS (2020)
Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients
V. Piccolo et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
Aristo Vojdani et al.
CLINICAL IMMUNOLOGY (2020)
SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases
I. Colmenero et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic
Anne Herman et al.
JAMA DERMATOLOGY (2020)
Perniosis during theCOVID-19 pandemic: Negativeanti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence ofSARS-CoV-2
Christine J. Ko et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Benjamin Israelow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Lack of association between chilblains outbreak and severe acute respiratory syndrome coronavirus 2: Histologic and serologic findings from a new immunoassay
Vivien Hebert et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries
Esther E. Freeman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Chilblain-like acral lesions during the COVID-19 pandemic (COVID): Histologic, immunofluorescence, and immunohistochemical study of 17 cases
Jean Kanitakis et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Shuchi Anand et al.
LANCET (2020)
Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral
Carsten Dittmayer et al.
LANCET (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19
Jesus F. Bermejo-Martin et al.
CRITICAL CARE (2020)
SARS-CoV-2 viral load is associated with increased disease severity and mortality
Jesse Fajnzylber et al.
NATURE COMMUNICATIONS (2020)
Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes
Ryan D. Molony et al.
SCIENCE SIGNALING (2017)
Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes
Ryan D. Molony et al.
SCIENCE SIGNALING (2017)
Cutaneous Adverse Events Associated with Interferon- a Treatment of Multiple Sclerosis
Annette Kolb-Maeurer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Mechanisms and Implications of Age-Associated Impaired Innate Interferon Secretion by Dendritic Cells: A Mini-Review
Anshu Agrawal
GERONTOLOGY (2013)
Impaired Interferon Signaling in Dendritic Cells From Older Donors Infected In Vitro With West Nile Virus
Feng Qian et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response
Alexander Panda et al.
JOURNAL OF IMMUNOLOGY (2010)
Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
Harlan S. Robins et al.
BLOOD (2009)
A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma
B Guillot et al.
DERMATOLOGY (2004)
Share Paper
